Molecular and Cellular Biology of Insulin-Like Growth Factors and Their Receptors 1989
DOI: 10.1007/978-1-4684-5685-1_7
|View full text |Cite
|
Sign up to set email alerts
|

Somatomedin Inhibitors

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

1990
1990
1990
1990

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 26 publications
0
2
0
Order By: Relevance
“…1988;Suikkari et al 1988: Baxter & Martin. 1989) and inhibitors (Phillips et al 1989). The dynamics of regulation of these factors presently is best understood in terms of some of the IGF-binding proteins, of which the 25-kD form (BP-1) appears to be particularly sensitive to insulin and nutritional status.…”
Section: E N D O C R I N E Role Of Igf-1mentioning
confidence: 99%
See 1 more Smart Citation
“…1988;Suikkari et al 1988: Baxter & Martin. 1989) and inhibitors (Phillips et al 1989). The dynamics of regulation of these factors presently is best understood in terms of some of the IGF-binding proteins, of which the 25-kD form (BP-1) appears to be particularly sensitive to insulin and nutritional status.…”
Section: E N D O C R I N E Role Of Igf-1mentioning
confidence: 99%
“…Levels of BP-1 rise severalfold in patients with poorly controlled diabetes, and fall promptly with insulin therapy (Suikkari et al 1988). High molecular-weight (MW) IGF inhibitors appear to lower circulating IGFs bioactivity in diabetes, malnutrition, and steroid excess, while low-MW IGF inhibitors are more important in kidney failure (Phillips et al 1989).…”
Section: E N D O C R I N E Role Of Igf-1mentioning
confidence: 99%